Skip to content
value.today

NeuroClear Technologies, Inc.

Total raised
$14 M
2 rounds on record
Latest round
$11 M
May 2020
First round on record
Aug 2019
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NeuroClear Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2020$11 MNo. 2$10 to $50 million

NeuroClear Technologies, Inc.: Raise no. 2, May 2020

Investors in this round

81 investors had bought by the notice of Jun 3, 2020: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $25 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$92,050
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nick Spring · Executive Officer, Director · Chief Executive Officer, Director
  • Steve Chaussy · Executive Officer · Chief Financial Officer
  • Steven King · Executive Officer · Chief Operating Officer
  • Anthony Zook · Director
  • Dennis Purcell · Director
  • Jeffrey O'Donnell · Director
  • Jerome Zeldis · Director · Director, Executive Chairman
  • Kenneth Londoner · Director
  • Michael Dougherty · Director
  • Natasha Drapeau · Director
  • Samuel Navarro · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Laidlaw & Company (UK) Ltd. (CRD 119037) · New York, New YorkSold in CA, CT, FL, MA, NC, PA, TX, VA, WA

Remarks in the notice

  • On fees: “Laidlaw is also entitled to warrants to purchase up to 6,575 shares of the issuer's common stock.”
  • On the amounts: “Represents 1,068,550 shares of common stock sold to investors at $10.00 per share and warrants to placement agent to purchase up to 6,575 common shares at $10.00 per share.”

Signed by Steve Chaussy, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 3, 2020. Read the notice at the SEC.

equitySEC
Aug 2019$3 MNo. 1$2 to $10 million

NeuroClear Technologies, Inc.: Raise no. 1, Aug 2019

Investors in this round

17 investors had bought by the notice of Aug 20, 2019: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth Londoner · Executive Officer, Director · Chief Executive Officer and Director of the Issuer
  • Natasha Drapeau · Executive Officer, Director · Director and Executive Vice President
  • Steve Chaussy · Executive Officer · Chief Financial Officer
  • Jeffrey O'Donnell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Londoner, Chairman and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 20, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NeuroClear Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2020).

    SEC Form D · Jun 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2020

That is all the official record says: NeuroClear Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NeuroClear Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 81 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NeuroClear Technologies, Inc.
NameRoleNamed in
Nick SpringChief Executive Officer, DirectorJun 2020
Steve ChaussyChief Financial OfficerJun 2020
Steven KingChief Operating OfficerJun 2020
Kenneth LondonerChief Executive Officer and Director of the IssuerAug 2019
Natasha DrapeauDirector and Executive Vice PresidentAug 2019
Anthony ZookDirectorJun 2020
Dennis PurcellDirectorJun 2020
Jeffrey O'DonnellDirectorJun 2020
Jerome ZeldisDirector, Executive ChairmanJun 2020
Kenneth LondonerDirectorJun 2020
Michael DoughertyDirectorJun 2020
Natasha DrapeauDirectorJun 2020
Nick SpringChief Executive Officer, DirectorJun 2020
Samuel NavarroDirectorJun 2020